Loveland, Anna B. https://orcid.org/0000-0001-9172-7747
Koh, Cha San
Ganesan, Robin https://orcid.org/0000-0003-1150-5189
Jacobson, Allan https://orcid.org/0000-0002-5661-3821
Korostelev, Andrei A. https://orcid.org/0000-0003-1588-717X
Article History
Received: 8 November 2022
Accepted: 2 May 2024
First Online: 8 May 2024
Competing interests
: A.J. is co-founder, director and consultant for PTC Therapeutics. The other authors declare no competing interests.